The origin of the bone scan as a tumour marker in prostate cancer.
AuthorsClarke, Noel W
AffiliationHope and Christie Hospitals, Manchester, UK
MetadataShow full item record
CitationThe origin of the bone scan as a tumour marker in prostate cancer. 2006, 50 (5):873-8 Eur. Urol.
- [Relation between serum PAP (prostate acid phosphatase) and bone scintigraphy in prostatic cancer].
- Authors: Aizawa T, Itoh T, Tsujino S, Namiki K, Miki M
- Issue date: 1992 Nov
- Re: Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.
- Authors: Andriole GL, Catalona WJ, Becich M
- Issue date: 1992 Feb
- [Cancer of the prostate: value of bone scintigraphy. Point of view].
- Authors: Lumbroso J, Guermazi F, Wibault P, Henry-Amar M, Travagli JP
- Issue date: 1985
- The bone scan as a monitor of prostatic cancer.
- Authors: Stone AR, Merrick MV, Chisholm GD
- Issue date: 1980 Dec
- Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications.
- Authors: Oesterling JE
- Issue date: 1993 Nov